Table 1.
Biological | Other Names | Commercial Name | Producer | Target |
---|---|---|---|---|
Siltuximab | Sylvant ** | IL-6 | ||
Clazakizumab | LD518 and BMS-945429 | Adler Biopharma | IL-6 | |
Olokizumab | UCB | IL-6 | ||
Vobarilizumab | Il-6R | |||
Olamkicept | FE-301; FE-999301; TJ-301 | Ferring | IL-6R | |
Sarilumab | Kevzara | Sanofi | IL-6R | |
Sirukumab ** | Janssen | IL-6 | ||
Olamkicept | Ferring | |||
Satralizumab | Sapelizumab, SA237 | Roche | IL-6R | |
Tocilizumab | Tocilizumab, Actemra e RoActemra. | Roche | IL-6R |
** this drug is approved for multicentric Castleman disease.